Webbestablished on mycophenolate and specialist team are satisfied that it is appropriate to share care. Disease & drug monitoring: Assess response to treatment and initiate any … WebbShared-care Guidelines Click here for a downloadable word document of the shared care agreement forms: DMARDs Shared Care Agreement (Version 1.1) Generic Shared Care Agreement Form BwD Adopted BP Adopted CSR Adopted EL Adopted FW Adopted GP Adopted MB Adopted WL Adopted ADHD Combined Adult and Child Date Posted: 01 - …

Shared Care Prescribing Information: Mycophenolate mofetil ...

WebbSHARED CARE AGREEMENT MYCOPHENOLATE mofetil- non transplant indications in adult services 1. REFERRAL CRITERIA • Shared Care is only appropriate if it provides the optimum solution for the patient. • Prescribing responsibility will only be transferred when it is agreed by the consultant and the WebbPatients in whom mycophenolate is contraindicated or not tolerated Initiation Shared care to be initiated once patient has been stable on maintenance dose for three months … chatinincognitobot

SHARED CARE GUIDELINE Mycophenolate for use in Neurology

Webb2. Consider request to prescribe under shared care arrangements and reply only if you do not agree to share care, in a timely manner within 14 days as outlined on page 7 with … http://www.yorkandscarboroughformulary.nhs.uk/docs/SC/Mycophenolate%20(non%20transplant)%20shared%20care%20%20June%202420%20final.pdf WebbSharing of care assumes communication between the specialist, GP and patient. The intention to share care should be explained to the patient by the doctor initiating treatment. It is important that patients are consulted about treatment and are in agreement with it. Patients with autoimmune conditions are under regular specialist follow-up. chat in group